. 2018 Aug 10;97(32):e11440. doi: 10.1097/MD.0000000000011440
Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
Figure 1.
Study selection procedure. CsA = ciclosporin, IFX = infliximab.